S&P Futures
4,230.75 +21.00 (+0.50%) Dow Futures
33,451.00 +147.00 (+0.44%) Nasdaq Futures
13,391.50 +80.25 (+0.60%) Russell 2000 Futures
1,986.50 +10.20 (+0.52%) Crude Oil
92.77 -1.57 (-1.66%) Gold
1,808.50 +1.30 (+0.07%)
INVO Bioscience, Inc. (INVO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.0600 |
| Open | 1.0200 |
| Bid | 1.0400 x 1000 |
| Ask | 1.0900 x 4000 |
| Day's Range | 1.0200 - 1.0767 |
| 52 Week Range | 0.6300 - 4.2800 |
| Volume | |
| Avg. Volume | 46,156 |
| Market Cap | 12.581M |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6260 |
| Earnings Date | Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.25 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for INVO
Related Research
- INVO BioScience, Inc.Market Update: CENT, EBAY, PFE, VMC, RKTStocks were mostly higher on Thursday morning amid more signs of moderating inflation. The Labor Department said that its producer price index for final demand fell 0.5% in July, down from a 1.0% increase in June. The reading was the first negative number since April 2020 and below the Reuters consensus forecast, which called for an increase of 0.2%. The Dow rose 0.5%, the S&P rose 0.4%, and the Nasdaq was flat. Crude oil rose 1.5% to $93.50 per barrel, while gold rose $8 to $1806 per ounce.RatingFair ValueEconomic Moat19 hours agoArgus Research
- PR Newswire
INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022
INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the IVC procedure it enables, will report financial results for its second quarter 2022, ended June 30, 2022, after the market close on Monday, August 15, 2022. The Company has scheduled a conference call that same day, Monday, August 15, 2022, at 4:30 pm ET, to review the results.
- PR Newswire
INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment
INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today announced that Dr. Sue Ellen Carpenter of Bloom Fertility, an INVO Center in Atlanta, will be hosting "Get to Know INVOcell" - a Facebook Live Event on July 7, 2022 at 7 PM ET.
- PR Newswire
INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China
INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today announced it has entered an exclusive distribution agreement with Onesky Holdings Limited ("Onesky") for Mainland China (excludes Hong Kong, Macau and Taiwan).
